Senescent cell clearance could be one of the big treatments to at least slow down one of the underlying causes of aging.
Senescent cells have stopped dividing and, even worse, secrete tens of biologically active proteins, including pro-inflammatory factors, proteases, pro-fibrotic factors and growth factors. This Senescence Associated Secretory Phenotype (SASP) can induce senescence in neighbouring cells and is associated with many age-related diseases.
Draft page - more coming soon.
Biotech company that specializes in the discovery and validation of microRNA biomarkers.
Fast generation of functional therapeutic antibodies.
University of Exeter spinout aiming to develop senotherapeutic interventions
Company that target cancer by developing senescence inducing and senolytic (senescent cell killing) compounds.
Company that develops and invests in drugs and technologies which prolong human lifespan.
Anti-aging company developing senoblockers.
Biopharmaceutical company focused on discovering and developing drugs against aging disorders and cancer.
Biotechnology company producing therapy that targets and destroys senescent cells.
Biotechnology company focused on development of treatments for age related diseases..
Cleara is developing therapeutics to eliminate senescent cells.
Tackling multiple dysfunctions together can stop ageing signs
Lifespan.io (LEAF) - 12-Feb-2021
NAD+ levels, senescence and chronic inflammation collectively influence ageingRead more...
Oisín Biotechnologies' gene therapy may be available in the next 5 years
Longevity Technology - 22-Jan-2021
Results in mice suggest that it can increase median lifespan in humans by 15 yearsRead more...
Whole-body senescent cell removal improved brain health in mice
Lifespan.io (LEAF) - 22-Jan-2021
Senolytic drug and cancer drug with quercetin improved age-related cognitionRead more...